Rubella virus IVDs
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
01-12-2017
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Available from:
R-Biopharm Pty Ltd
Class:
Class 3
Manufactured by:
Diesse Diagnostica Senese SPA Strada Dei Laghi 39, Monteriggioni, 53035 Italy
Therapeutic area:
CT771 - Rubella virus IVDs
Therapeutic indications:
Determination of antibodies to rubella virus in human serum.
Authorization status:
A
Authorization date:
2014-04-22
